Showing results (1221-1230 of 1,356) with videos related to

Sort By:
Pageof 136
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
Diagnostic Performance of [<sup>18</sup>F]PSMA-1007 PET/CT on Proven PSMA-Positive Hepatocellular Carcinoma: A Prospective Clinical StudyKerstin Michalski, Florian P Reiter, Aleksander Kosmala, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|December 21, 2013
Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocalityK Cupisti, N Lehwald, M Anlauf, et al.
Toxicology and Applied Pharmacology|May 18, 2021
Mercapturate pathway metabolites of sotorasib, a covalent inhibitor of KRAS<sup>G12C</sup>, are associated with renal toxicity in the Sprague Dawley ratJonathan A Werner, Rhian Davies, Jan Wahlstrom, et al.
HNO|April 3, 2016
[Multicenter trial for sudden hearing loss therapy - planning and concept]S K Plontke, M Girndt, C Meisner, et al.
Journal of Neuroimmunology|December 6, 2021
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancerMichelle C Janelsins, Lianlian Lei, Colleen Netherby-Winslow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
Predictive Value of <sup>18</sup>F-FDG PET in Patients with Advanced Medullary Thyroid Carcinoma Treated with VandetanibRudolf A Werner, Jan-Stefan Schmid, Takahiro Higuchi, et al.
Scientific Reports|September 14, 2017
Survivin and XIAP - two potential biological targets in follicular thyroid carcinomaThomas A Werner, Levent Dizdar, Inga Nolten, et al.
Nuclear Medicine Communications|February 22, 2023
Wnt/β-catenin modulating drugs regulate somatostatin receptor expression and internalization of radiolabelled octreotide in neuroendocrine tumor cellsAlexander Weich, Dorothea Rogoll, Melissa Peschka, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2025
Refining the clinical utility of [<sup>177</sup>Lu]Lu/[<sup>225</sup>Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancerLiam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Endocrine|May 4, 2016
Assessment of tumor heterogeneity in treatment-naïve adrenocortical cancer patients using (18)F-FDG positron emission tomographyRudolf A Werner, Matthias Kroiss, Masatoyo Nakajo, et al.
Pageof 136